Savara Pharmaceuticals
SVRA
#6474
Rank
S$0.77 B
Marketcap
$4.52
Share price
3.70%
Change (1 day)
-7.15%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$73.64 Million a decrease over its 2022 earnings that were of -S$51.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion37.92%
2023 -S$73.64 Million43.38%
2022 -S$51.36 Million-11.31%
2021 -S$57.91 Million-13.3%
2020 -S$66.8 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$92.51 Million105.54%
2017 -S$45.01 Million34.11%
2016 -S$33.56 Million-37.43%
2015 -S$53.64 Million38.81%
2014 -S$38.64 Million33.62%
2013 -S$28.92 Million38.49%
2012 -S$20.89 Million24.59%
2011 -S$16.76 Million-36.5%
2010 -S$26.4 Million-3.14%
2009 -S$27.25 Million-23.28%
2008 -S$35.52 Million8.52%
2007 -S$32.73 Million-34.14%
2006 -S$49.7 Million184.43%
2005 -S$17.48 Million90.75%
2004 -S$9.16 Million190.35%
2003 -S$3.16 Million11.64%
2002 -S$2.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$24.45 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.33 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA